Zats Liat Peretz, Ahmad Labiba, Casden Natania, Lee Meelim J, Belzer Vitali, Adato Orit, Bar Cohen Shaked, Ko Seung-Hyun B, Filbin Mariella G, Unger Ron, Lauffenburger Douglas A, Segal Rosalind A, Behar Oded
Department of Developmental Biology and Cancer Research, Faculty of Medicine, The Institute for Medical Research Israel-Canada, The Hebrew University, Jerusalem, Israel.
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA.
Neurooncol Adv. 2022 Jul 21;4(1):vdac117. doi: 10.1093/noajnl/vdac117. eCollection 2022 Jan-Dec.
High-grade gliomas (HGG) in children have a devastating prognosis and occur in a remarkable spatiotemporal pattern. Diffuse midline gliomas (DMG), including diffuse intrinsic pontine gliomas (DIPG), typically occur in mid-childhood, while cortical HGGs are more frequent in older children and adults. The mechanisms behind this pattern are not clear.
We used mouse organotypic slice cultures and glial cell cultures to test the impact of the microenvironment on human DIPG cells. Comparing the expression between brainstem and cortical microglia identified differentially expressed secreted proteins. The impact of some of these proteins on DIPGs was tested.
DIPGs, pediatric HGGs of brainstem origin, survive and divide more in organotypic slice cultures originating in the brainstem as compared to the cortex. Moreover, brainstem microglia are better able to support tumors of brainstem origin. A comparison between the two microglial populations revealed differentially expressed genes. One such gene, interleukin-33 (IL33), is highly expressed in the pons of young mice and its DIPG receptor is upregulated in this context. Consistent with this observation, the expression levels of IL33 and its receptor, IL1RL1, are higher in DIPG biopsies compared to low-grade cortical gliomas. Furthermore, IL33 can enhance proliferation and clonability of HGGs of brainstem origin, while blocking IL33 in brainstem organotypic slice cultures reduced the proliferation of these tumor cells.
Crosstalk between DIPGs and the brainstem microenvironment, in particular microglia, through IL33 and other secreted factors, modulates spatiotemporal patterning of this HGG and could prove to be an important future therapeutic target.
儿童高级别胶质瘤(HGG)预后极差,且呈现出显著的时空模式。弥漫性中线胶质瘤(DMG),包括弥漫性脑桥内胶质瘤(DIPG),通常发生在儿童中期,而皮质HGG在大龄儿童和成人中更为常见。这种模式背后的机制尚不清楚。
我们使用小鼠器官型切片培养和胶质细胞培养来测试微环境对人DIPG细胞的影响。比较脑干和皮质小胶质细胞之间的表达,确定差异表达的分泌蛋白。测试了其中一些蛋白对DIPG的影响。
与皮质来源的器官型切片培养相比,脑干来源的小儿HGG即DIPG在脑干来源的器官型切片培养中存活和增殖更多。此外,脑干小胶质细胞更能支持脑干来源的肿瘤。对这两种小胶质细胞群体的比较揭示了差异表达的基因。其中一个基因,白细胞介素-33(IL33),在幼鼠脑桥中高表达,其DIPG受体在这种情况下上调。与这一观察结果一致,与低级别皮质胶质瘤相比,DIPG活检组织中IL33及其受体IL1RL1的表达水平更高。此外,IL33可以增强脑干来源的HGG的增殖和克隆能力,而在脑干器官型切片培养中阻断IL33可降低这些肿瘤细胞的增殖。
DIPG与脑干微环境,特别是小胶质细胞之间通过IL33和其他分泌因子的相互作用调节了这种HGG的时空模式,可能成为未来重要的治疗靶点。